Article Text

Download PDFPDF
Exploring the ChatGPT platform with scenario-specific prompts for vaping cessation
  1. Samia Amin,
  2. Crissy Terawaki Kawamoto,
  3. Pallav Pokhrel
  1. Population Sciences in the Pacific Program, University of Hawai'i Cancer Center, Honolulu, Hawaii, USA
  1. Correspondence to Dr Samia Amin, University of Hawai'i Cancer Center, Honolulu, HI 96813, USA; samin{at}cc.hawaii.edu

Abstract

Objective To evaluate and start a discussion on the potential usefulness of applying Artificial Intelligence (AI)-driven natural language processing technology such as the ChatGPT in tobacco control efforts, specifically vaping cessation.

Method Ten real-world questions about vaping cessation were selected from a Reddit forum and used as ChatGPT prompts or queries. Content analysis was performed on the ChatGPT responses to identify the thematic aspects of vaping cessation support represented in the responses. Next, the responses were empirically evaluated by five experts in tobacco control on accuracy, quality, clarity, and empathy.

Result The following themes related to vaping cessation support were identified: understanding nicotine withdrawal symptoms, self-regulation, peer support, motivational support, and Nicotine Replacement Therapy (NRT). The experts judged the ChatGPT responses to be 'satisfactory' to 'excellent' in areas of accuracy, quality, clarity, and empathy.

Conclusion If managed by a group of experts, including clinicians, and behavioral and computer scientists, a platform such as the ChatGPT may be leveraged to design tailored interventions for tobacco use cessation, including vaping cessation.

  • Cessation
  • ChatGPT
  • E-Cigarettes
  • Quit
  • Vaping

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors SA: conceptualisation, writing—original draft, writing—review and editing. CK: writing—review and editing. PP: conceptualisation, writing—original draft, writing—review and editing, supervision.

  • Funding The study was supported by funds from the National Cancer Institute (R01CA228905).

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.